Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)

NCT04942080 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT04942080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04942080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of CALR Allele Burden in Diagnosis and Follow-up of Patients With CALR Mutated Myeloproliferative Syndromes (CALRSUIVI)
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Recruiting
Start date
October 28, 2021
Completion date
April 28, 2030
Enrollment
260 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia, myeloproliferative neoplasm, primary myelofibrosis, fibrotic stage, primary myelofibrosis, prefibrotic stage